Back to User profile » Dr Brendan Clark
Papers published by Dr Brendan Clark:
Comparable Clinical Outcomes with Tiotropium/Olodaterol or Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with COPD and Blood Eosinophil Count ≤300 Cells/μL
Sethi S, Clark B, Buysman EK, Sargent A, Bengtson LG
International Journal of Chronic Obstructive Pulmonary Disease 2025, 20:3327-3338
Published Date: 25 September 2025
Obesity Medication Treatment Perspectives Among People with Overweight or Obesity
Ostrominski JW, Chhibber A, Kuti EL, Clark B, Donato BM
Patient Preference and Adherence 2025, 19:2887-2899
Published Date: 13 September 2025
Clinical and Economic Evaluation of Fluticasone Furoate/Umeclidinium/Vilanterol Versus Tiotropium/Olodaterol Therapy in Maintenance Treatment–Naive Patients with COPD in the US
Shaikh A, Ritz J, Casciano J, Palli SR, Clark B, Dotiwala Z, Quint JK
International Journal of Chronic Obstructive Pulmonary Disease 2025, 20:335-348
Published Date: 14 February 2025
Healthcare Resource Utilization, Cost and Clinical Outcomes in Patients Diagnosed with COPD Initiating Tiotropium Bromide/Olodaterol versus Fluticasone Furoate/Umeclidinium/Vilanterol Based on Exacerbation History
Sethi S, Clark B, Bengtson LG, Buysman EK, Palli S, Sargent A, Shaikh A, Ferguson GT
International Journal of Chronic Obstructive Pulmonary Disease 2023, 18:625-641
Published Date: 19 April 2023
Costs and Clinical Consequences of Compliance with COPD GOLD Recommendations or National Guidelines Compared with Current Clinical Practice in Belgium, Germany, Sweden, and the United States
Sethi S, Wright A, Hartgers-Gubbels ES, Hechtner M, Clark B, Wright C, Langham S, Buhl R
International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:2149-2160
Published Date: 7 September 2022
Low Peak Inspiratory Flow Rates are Common Among COPD Inpatients and are Associated with Increased Healthcare Resource Utilization: A Retrospective Cohort Study
Clark B, Wells BJ, Saha AK, Franchino-Elder J, Shaikh A, Donato BMK, Ohar JA
International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:1483-1494
Published Date: 29 June 2022